Breaking News
2 Millionaire-Maker Artificial Intelligence (AI) Stocks
The article highlights Oracle and Tesla as two AI stocks with significant growth potential. Oracle's cloud computing segment is growing rapidly at 34% year-over-year, driven by major deals like its $300 billion agreement with OpenAI, though the company has taken on substantial debt to fund data center expansion. Tesla is pivoting toward mass production of its Optimus humanoid robot, with plans to launch at $20,000-$30,000 by end of next year, potentially transforming the company beyond electric vehicles.
Latest News
2 Millionaire-Maker Artificial Intelligence (AI) Stocks
The article highlights Oracle and Tesla as two AI stocks with significant growth potential. Oracle's cloud computing segment is growing rapidly at 34% year-over-year, driven by major deals like its $300 billion agreement with OpenAI, though the company has taken on substantial debt to fund data center expansion. Tesla is pivoting toward mass production of its Optimus humanoid robot, with plans to launch at $20,000-$30,000 by end of next year, potentially transforming the company beyond electric vehicles.
Century Aluminum EVP Sells $2.3M Worth of Shares
Gunnar Gudlaugsson, EVP of Global Operations at Century Aluminum, sold 43,000 shares worth $2.3 million on February 25, 2026, reducing his direct holdings by 24%. Despite the insider sale, the company remains well-positioned with a landmark partnership with Emirates Global Aluminum to build the first U.S. aluminum smelting plant in 47 years, expected to create 1,000 jobs. Century Aluminum's stock has surged 166% over the past year and is up 31% in 2026.
VTGN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
A securities class action lawsuit has been filed against Vistagen Therapeutics regarding alleged material misstatements about its fasedienol drug development for social anxiety disorder. Investors who purchased VTGN stock between April 1, 2024 and December 16, 2025 may be eligible for compensation. The lead plaintiff deadline is March 16, 2026.
הודעה על מועד אחרון לתביעה נגד VTGN: רוזן, יועץ מהימן למשקיעים, מעודד את משקיעי Vistagen Therapeutics, Inc להשיג ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – VTGN
Rosen Law Firm announces a March 16, 2026 deadline for investors to join a securities class action lawsuit against Vistagen Therapeutics, Inc. (VTGN). The lawsuit alleges that company defendants made misleading positive statements about the fasedienol drug trial (PALISADE-3) for acute social anxiety disorder treatment while concealing material negative facts, causing shareholders to purchase stock at artificially inflated prices.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Paysafe Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – PSFE
Rosen Law Firm is notifying investors who purchased Paysafe Limited securities between March 4, 2025 and November 12, 2025 of an April 7, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Paysafe made false statements regarding its ecommerce business exposure to high-risk clients, understated credit loss reserves, and failed to disclose issues with merchant category codes that would impact revenue growth and ability to meet financial guidance.
ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG
A securities class action lawsuit has been filed against Plug Power Inc. (PLUG) for allegedly making false and misleading statements regarding a U.S. Department of Energy loan and hydrogen production facilities. Investors who purchased PLUG securities between January 17, 2025 and November 13, 2025 may be eligible for compensation. The lead plaintiff deadline is April 3, 2026.
ROSEN, LEADING INVESTOR COUNSEL, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR
A securities class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) for allegedly making false and misleading statements regarding its partnership with ENTRA1 Energy LLC. The lawsuit claims NuScale failed to disclose that ENTRA1 lacked significant experience in nuclear power generation and that the company's commercialization strategy was exposed to material undisclosed risks. Investors who purchased NuScale Class A common stock between May 13, 2025 and November 6, 2025 may be eligible for compensation. The lead plaintiff deadline is April 20, 2026.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
A securities class action lawsuit has been filed against REGENXBIO, Inc. for allegedly providing materially false and misleading statements regarding the efficacy and safety of its RGX-111 gene therapy trial for Hurler syndrome. Investors who purchased REGENXBIO securities between February 9, 2022 and January 27, 2026 may be entitled to compensation. The deadline to serve as lead plaintiff is April 14, 2026.
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
A securities class action lawsuit has been filed against Mereo BioPharma Group plc (MREO) for allegedly providing misleading statements about Phase 3 clinical trials for setrusumab. The company reportedly made positive statements about the drug's potential while concealing that the ORBIT and COSMIC studies failed to meet their primary endpoints. Investors who purchased ADSs between June 5, 2023 and December 26, 2025 may be eligible for compensation. The lead plaintiff deadline is April 6, 2026.
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Snowflake Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNOW
Rosen Law Firm has filed a class action lawsuit on behalf of Snowflake Inc. investors who purchased Class A common stock between June 27, 2023 and February 28, 2024. The lawsuit alleges that Snowflake made positive statements about business performance while failing to disclose that product efficiency gains, Iceberg Tables, and tiered storage pricing would materially negatively impact consumption and revenues. The lead plaintiff deadline is April 27, 2026.